Glutathione and glutamate levels in the diaphragm of patients with chronic obstructive pulmonary disease

Engelen M.P.K.J., Orozco-Levi M., Deutz N.E.P., Barreiro E., Hernandez N., Wouters E.F.M., Gea J., Schols A.M.W.J.

Source: Eur Respir J 2004; 23: 545-551
Journal Issue: April
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Engelen M.P.K.J., Orozco-Levi M., Deutz N.E.P., Barreiro E., Hernandez N., Wouters E.F.M., Gea J., Schols A.M.W.J.. Glutathione and glutamate levels in the diaphragm of patients with chronic obstructive pulmonary disease. Eur Respir J 2004; 23: 545-551

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Changes in antioxidant enzyme levels in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Year: 2009


Oxidant metabolism in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 14S-27S
Year: 2003



Extracellular ATP as a biomarker of severity of chronic obstructive pulmonary disease
Source: International Congress 2019 – Injury and repair: less is more
Year: 2019




Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 23: 629-636
Year: 2004



Limitation to muscular activity in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 6-7
Year: 2004


Rhinovirus-infection in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002

Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2013; 62: 1-18
Year: 2013


Chronic obstructive pulmonary disease
Source: Eur Respir Mon; 2009: 45: 25–31
Year: 2009

Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2014; 65: 1-17
Year: 2014


Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2015; 70: 80-98
Year: 2015


Systemic effects of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 347-360
Year: 2003



Systemic inflammation in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 5S-13S
Year: 2003



Chronic pain in patients with chronic obstructive pulmonary disease
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018


Systemic and pulmonary inflammation in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pathophysiology of COPD
Year: 2008


Activity limitations in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Physical activity, methodology and impact
Year: 2011


Inferon administration to patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009

Systemic inflammation and increased arterial stiffness in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006


IL-8 in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 364s
Year: 2001

Systemic vascular function in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Increased arterial stiffness in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 65s
Year: 2006